MedPath

Analgesic Efficacy of Local Anesthetic Transversus Abdominis Plane (TAP) Blocks in Abdominal Surgery

Phase 1
Completed
Conditions
Pain
Interventions
Procedure: US-Guided Ropivacaine TAP Block
Registration Number
NCT00682136
Lead Sponsor
Hunter Colorectal Research
Brief Summary

The aim of the study is to establish the efficacy of local anaesthetic TAP (transversus abdominis plane) blocks in providing pain relief in the first 24hrs following open or laparoscopic elective abdominal colorectal operations.

TAP blocks involve the injection of local aesthetic (ropivicaine) into the transversus abdominis plane in the abdominal wall. This injection takes place after induction of anaesthesia, but before the commencement of surgery. TAP blocks have been proposed as a potential safer alternative to epidural anaesthesia. The blocks have been extensively used in the Hunter New England system over the last 18 months. As yet there is no clear evidence for there efficacy, hence the need for this trial.

This trial would establish the efficacy of this practice. If the technique proves effective it could be widely used and provide a simpler method of managing post operative pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
206
Inclusion Criteria
  • All patients aged 18 and over undergoing elective open or laparoscopic colorectal surgery performed by the participating surgeons within the study period will be considered for the trial.
Exclusion Criteria
  • History of adverse reaction to Ropivicaine or similar drug.
  • Inability or refusal to give consent
  • Coagulopathic
  • Severe renal impairment
  • Aged <18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1US-Guided Ropivacaine TAP BlockOpen Laparotomy Arm: All patients enrolled in the study who are undergoing elective open laparotomy surgery.
2US-Guided Ropivacaine TAP BlockLaparoscopic Arm: All patients enrolled in the study who are undergoing elective laparoscopic abdominal surgery.
Primary Outcome Measures
NameTimeMethod
mg/kg of morphine equivalent used by patients post operatively.From operation until discharge.
Secondary Outcome Measures
NameTimeMethod
Lung Function (spirometry), including FVC, FEV1 and PEFR24, 48 and 72 hours postoperatively
Visual Analogue Scale for pain at rest, deep breathing and coughing.24, 48 and 72 hours postoperatively

Trial Locations

Locations (4)

John Hunter Hospital

🇦🇺

New Lambton, New South Wales, Australia

Mater Misericordiae Hospital

🇦🇺

Waratah, New South Wales, Australia

Newcastle Private Hospital

🇦🇺

New Lambton, New South Wales, Australia

Private Medical Suites

🇦🇺

New Lambton, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath